Print Page | Sign In | Join Today
Virginia Bio Blog
Blog Home All Blogs
Search all posts for:   


View all (12) posts »

Key Concepts Used to Evaluate Life Sciences Assets

Posted By Administration, Tuesday, January 23, 2018
Updated: Monday, January 22, 2018

If you are: a) an entrepreneur who is raising funding, licensing an asset, or selling your company, b) are a private investor who wants to estimate and negotiate start-up share value, or c) any other professional who is active in the investment sector, this white paper is for you.  Benefit from this overview of the key concepts used in life sciences valuation, and click the button below to get your copy now.


This white paper will offer insightful details on:

  • The various valuation methodologies used to assign a value to life science businesses and assets

  • The methodologies used, in particular, by pharma partners and venture capitalists

  • An explanation of three fundamental concepts in valuation:  risk-adjusted value, cost of capital, and present value   

After reading the white paper, to learn more about exclusive savings with ShareVault for Virginia Bio members.  ShareVault is a secure document sharing solution ideally suited for life sciences companies, allowing for bank-grade secure sharing of highly confidential documents with third parties.

This post has not been tagged.

Share |
Permalink | Comments (0)

Our Sponsors

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected